Web-Based Amblyopia Decision Support Tool
May 7, 2026 - 13:44
Radio and PodcastLive Radio & Podcasts
Health
Mammalian Target Rapamycin Inhibition for Proliferative Vitreoretinopathy
Interview with Ehsan Rahimy, MD, author of Mammalian Target Rapamycin Inhibition as a Therapeutic Target for Prevention of Proliferative Vitreoretinopathy. Hosted by Neil Bressler, MD. Related Content: Mammalian Target R...
About This Episode
Mammalian Target Rapamycin Inhibition for Proliferative Vitreoretinopathy is an episode from JAMA Ophthalmology Author Interviews: Covering research, science, & clinical practice in ophthalmology and vision science by American Medical Assoc...
Podcast
This episode belongs to JAMA Ophthalmology Author Interviews: Covering research, science, & clinical practice in ophthalmology and vision science.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Aug 7, 2025, 17:32 long, audio available.
Related Episodes
Continue listening to more episodes from JAMA Ophthalmology Author Interviews: Covering research, science, & clinical practice in ophthalmology and vision science.
Geographic Atrophy Enlargement Rates in the AREDS2 Study
Apr 2, 2026 - 14:19
Prevalence and Health Care Disparities of Retinal Conditions
Mar 19, 2026 - 13:31
Support, Educate, Empower Program and Medication Adherence
Feb 26, 2026 - 17:21
Language Accessibility at Select Academic Ophthalmology Centers
Jan 15, 2026 - 12:44
Aflibercept Dose in Polypoidal Choroidal Vasculopathy
Dec 18, 2025 - 16:55
Foundation Models vs Physicians in Ophthalmological Questions
Nov 13, 2025 - 15:44
Questions About This Episode
What is Mammalian Target Rapamycin Inhibition for Proliferative Vitreoretinopathy about?
Interview with Ehsan Rahimy, MD, author of Mammalian Target Rapamycin Inhibition as a Therapeutic Target for Prevention of Proliferative Vitreoretinopathy. Hosted by Neil Bressler, MD. Related Content: Mammalian Target Rapamycin Inhibition as a Therapeutic Target for Prevention of Proliferative Vitreoretinopathy
Where can I listen to Mammalian Target Rapamycin Inhibition for Proliferative Vitreoretinopathy?
You can listen to Mammalian Target Rapamycin Inhibition for Proliferative Vitreoretinopathy online on Radio and Podcast. Open the player on this page to stream the available audio.
Which podcast is Mammalian Target Rapamycin Inhibition for Proliferative Vitreoretinopathy from?
Mammalian Target Rapamycin Inhibition for Proliferative Vitreoretinopathy is an episode from JAMA Ophthalmology Author Interviews: Covering research, science, & clinical practice in ophthalmology and vision science by American Medical Association.
How long is this episode?
This episode is 17:32 long.
When was this episode published?
This episode was published on Aug 7, 2025.
Can I save Mammalian Target Rapamycin Inhibition for Proliferative Vitreoretinopathy for later?
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Are there related episodes from JAMA Ophthalmology Author Interviews: Covering research, science, & clinical practice in ophthalmology and vision science?
Yes. This page shows related episodes from JAMA Ophthalmology Author Interviews: Covering research, science, & clinical practice in ophthalmology and vision science when more episodes are available from the podcast feed.
Quick Answers About This Episode
Where can I listen to Mammalian Target Rapamycin Inhibition for Proliferative Vitreoretinopathy?
You can listen to Mammalian Target Rapamycin Inhibition for Proliferative Vitreoretinopathy on this page when the episode audio is available from the podcast feed.
Which podcast is this episode from?
Mammalian Target Rapamycin Inhibition for Proliferative Vitreoretinopathy is from JAMA Ophthalmology Author Interviews: Covering research, science, & clinical practice in ophthalmology and vision science by American Medical Association.
What are the episode details?
Published Aug 7, 2025 and 17:32 long